SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotechnology Value Fund, L.P.
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Biomaven who wrote (1085)12/1/1999 2:35:00 PM
From: NeuroInvestmentRead Replies (2) of 4974
 
Absolutely. You would expect to see it in depression and anxiety trials, where cognitive interventions have been demonstrated to directly impact brain metabolism (PET scan activity) much as pharmaceutical interventions do. But one also finds it elsewhere where it is baffling--like a stroke trial where the placebo group showed an improvement in infarct size that was far above historically-based expectations. Pain, Alzheimer's, Parkinson's...offhand I am having trouble thinking of a neuro/psycho disorder where it isnt--well perhaps if one were treating severe head trauma where the recipient is unconscious--but you still have an indirect placebo effect, the treatment staff being more motivated and providing a higher level of care in the belief that something 'special' is being given.

NeuroInvestment (www.neuroinvestment.com)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News